Meiji Seika to push new vaccine with SII in India

Meiji Seika, SII tie up to bring Japanese Encephalitis vaccine to India; Medreich eyes expansion TOKYO: Meiji Seika Pharma-owned Medreich Pharma is eyeing inorganic growth and more generics supply from India, while the parent has tied up with Serum Institute of India (SII) to launch Japanese Encephalitis vaccine in the country.“SII will take the required…

Read More

Resona Bank deepens ties with Tata Cap

MUMBAI: Japan’s Resona Bank on Monday announced a tie-up with Tata Capital to provide its clients better access to financing solutions and opportunities in India using the non-bank lender’s local network. The announcement follows a $20 million investment by Resona Bank as a limited partner in Tata Capital Growth Fund III LP, which invests in…

Read More

UPI@10: How platform changed the way we pay

UPI completes 10 years, growing from 1.8 crore transactions in FY17 to 24,162 crore in FY26 MUMBAI: Nearly one in two real-time payments in the world happen on the UPI platform. From 1.8 crore transactions in FY17, the year it was launched, to 24,162 crore transactions in FY26, UPI transactions have grown 13,000 times.Today, the…

Read More